HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

Rhea-AI Summary

Harmony Biosciences Holdings (Nasdaq: HRMY) will participate in several upcoming investor conferences. These events include the Oppenheimer 33rd Annual Healthcare Conference on March 14, 2023, and the Needham Neuroscience Forum on March 15, 2023, both held virtually, along with the Jefferies Biotech on the Bay Summit in Miami, FL on March 17, 2023. The fireside chats will be available for webcast on Harmony's investor page. This participation highlights Harmony's commitment to advancing therapies for rare neurological diseases.

PLYMOUTH MEETING, Pa., March 6, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that Harmony's management team will participate in the following upcoming investor conferences:

Oppenheimer 33rd Annual Healthcare Conference

• Location: Virtual
• Fireside Chat: Tuesday, March 14, 2023, at 8:00 a.m. ET
• 1x1 Meetings: Tuesday, March 14, 2023

2nd Annual Needham Neuroscience Forum

• Location: Virtual
• Fireside Chat: Wednesday, March 15, 2023, at 8:00 a.m. ET

Jefferies Biotech on the Bay Summit

• Location: Miami, FL
• 1x1 Meetings: Friday, March 17, 2023

A webcast of the fireside chats will be available on the investor page of Harmony's website at https://ir.harmonybiosciences.com/.

About Harmony Biosciences
At Harmony Biosciences, we specialize in developing and delivering treatments for rare neurological diseases that others often overlook. We believe that where empathy and innovation meet, a better life can begin for people living with neurological diseases. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, PA, our team of experts from a wide variety of disciplines and experiences is driven by our shared conviction that innovative science translates into therapeutic possibilities for our patients, who are at the heart of everything we do. For more information, please visit www.harmonybiosciences.com.

Harmony Biosciences Investor Contact:
Luis Sanay, CFA
445-235-8386
lsanay@harmonybiosciences.com 

Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086
cmccanless@harmonybiosciences.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-participate-in-upcoming-investor-conferences-301762537.html

SOURCE Harmony Biosciences

FAQ

What investor conferences will Harmony Biosciences attend in March 2023?

Harmony Biosciences will attend the Oppenheimer 33rd Annual Healthcare Conference on March 14, the Needham Neuroscience Forum on March 15, and the Jefferies Biotech on the Bay Summit in Miami, FL on March 17.

When is the fireside chat at the Oppenheimer Healthcare Conference?

The fireside chat at the Oppenheimer 33rd Annual Healthcare Conference will take place on March 14, 2023, at 8:00 a.m. ET.

Where can I watch Harmony Biosciences' investor conference presentations?

You can watch the presentations on Harmony Biosciences' investor page, available at https://ir.harmonybiosciences.com/.

What is the focus of Harmony Biosciences?

Harmony Biosciences focuses on developing innovative therapies for patients with rare neurological diseases.

What is the stock symbol for Harmony Biosciences?

The stock symbol for Harmony Biosciences is HRMY, and it is listed on Nasdaq.